Elix, Inc. is an AI drug discovery and materials informatics company with the mission of "Rethinking Drug Discovery and Materials Development".
We support our clients from pharmaceutical companies, chemical manufacturers and academia through collaborative research.
Our clients are mainly from pharmaceutical companies, chemical manufacturers and academia.
We conduct joint research with our partners through Elix's AI drug discovery platform Elix DiscoveryTM for Pharma.
This platform brings cutting-edge technologies together to rapidly improve a range of tasks, mainly from hit-to-lead optimization.
Our main focus is on small molecules, but we can also handle other modalities such as antibodies.
Elix DiscoveryTM for Materials is a state-of-the-art MI platform that allows you to efficiently search for materials with superior properties to help improve your business. We also support you to make the best use of MI even with few data samples.
In addition to talented AI researchers and AI engineers, many of the team members have Ph.D. degrees and come from different specialities such as chemistry, biology and physics. This diverse lineup gives us the capability to always be on the cutting-edge of AI research and development.
We offer full assistance, from:
- Proposing the most promising model among the latest research in deep learning.
- Implementation of our selected model.
- Refinement and model optimization.
